Epitel, Inc., a leader in AI-driven wireless brain health technologies, announced today the closing of a $26 million Series B financing co-led by Catalyst Health Ventures and Genoa Ventures, with ...

The job market feels upside down. Experienced office workers are getting laid off, while hospitals, factories, utilities, ...

Rugonersen, a potentially best-in-class antisense oligonucleotide (ASO) therapy in development for Angelman syndrome, advanced into the pivotal ...

Alkermes PLC (ALKS) reports significant sales growth and strategic advancements, while navigating potential market competition and profitability hurdles.

Riding a bike, reading a book or folding laundry while watching TV can feel effortless, almost like your brain does it on ...

Key Points Interested in Alkermes plc? Here are five stocks we like better. Alkermes reported strong Q2 performance: Revenue ...

Hormonal health is a significant health system and workforce challenge, with nearly 40% of women not knowing where to seek care and only 13% of employers having access to adequate employer sponsored ...

A new generation of neurotechnology is rapidly transitioning from clinical laboratories into the modern workplace. Wearable electroencephalography (EEG) ...

Transaction to provide Oak Hill Bio with approximately $175 million in gross proceeds, including $75 million of cash in Research Alliance ...

Transaction to provide Oak Hill Bio with approximately $175 million in gross proceeds, including $75 million of cash in Research Alliance Corporation III’s (Nasdaq: RACC) (“RA ...